Fig. 4: Kaplan-Meier (KM) curves for different risk groups.

KM curves for the high-risk (\({\rm{PI}} \,>\, {{\rm{PI}}}_{{\rm{med}}}\)) and low-risk (\({\rm{PI}}\le {{\rm{PI}}}_{{\rm{med}}}\)) patient groups in the testing set of: a TCGA-BRCA dataset; b TCGA-OV dataset; c ICGC-OVAU dataset; d Caldas-BC dataset. \({{\rm{PI}}}_{{\rm{med}}}\) for each dataset is derived from the corresponding tuning set patients.